Expert Interview
Reviewing the additional data from BridgeBio phase 3 attribute-cm study showing acoramidis increases serum transthyretin in transthyretin amyloid cardiomyopathy (ATTR-CM)
Ticker(s): BBIOInstitution: Brigham and Women's | Harvard
- Associate Physician in Cardiovascular Medicine at BWH and an Instructor in Medicine at Harvard Medical School.
- Manages 200 patients with cardiac amyloidosis.
- Research interests have focused on the use of imaging in cardiac amyloidosis, particularly for early detection of disease and to track response to therapy; site-PI in two large multi-center phase 3 trials of novel gene-silencers in transthyretin cardiac amyloidosis (ATTR).
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
